Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

IDX/KAEF stock hub

IDX/KAEF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IDX/KAEFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5T

Indonesia Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IDX/KAEF

In the news

Latest news · IDX/KAEF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.4P50 14.4P75 23.9

Trailing P/En/a

P25 11.5P50 23.8P75 52.6

ROE-6.2

P25 0.6P50 5.1P75 12.2

ROIC-0.5

P25 1.3P50 6P75 11.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IDX/KAEF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

IDR

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	9,838
Employees Change	3,892%
Employees Change Percent	65.46
Enterprise value	IDR 9.8T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Distribution
Isin	ID1000070303
Last refreshed	2026-05-10
Market cap	IDR 3.5T
Price	IDR 635
Price currency	IDR
Rev Per Employee	923,538,292.84x
Sector	Healthcare
Sic	2834
Symbol	idx/KAEF
Website	https://www.kimiafarma.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.48%
EV Earnings	-61.96x
EV/EBITDA	21.44x
EV/FCF	27.22x
EV/Sales	1.08x
FCF yield	10.2%
P/B ratio	1.24x
P/S ratio	0.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.47%
EBITDA Margin	3.53%
FCF margin	3.97%
Gross margin	32.44%
Gross Profit	IDR 2.9T
Gross Profit Growth	9.9%
Gross Profit Growth Q	22.79%
Gross Profit Growth3 Y	-6.75%
Gross Profit Growth5 Y	-2.46%
Net Income	IDR -158.3B
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	-2.01%
Profit Margin	-1.74%
Profit Per Employee	IDR -16.1M
ROA	-0.18
Roa5y	-0.88
ROCE	-0.52
ROE	-6.15
Roe5y	-15.32
ROIC	-0.45
Roic5y	-2.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-5.7%
Cagr15y	9.22%
Cagr1y	36.88%
Cagr20y	7.5%
Cagr3y	-9.79%
Cagr5y	-24.8%
Div CAGR10	3.86%
Div CAGR3	2.91%
Div CAGR5	11.14%
EPS Growth Quarters	6
EPS Growth Years	2
FCF Growth5 Y	14.15%
OCF Growth10 Y	49.48%
OCF Growth5 Y	-7.56%
Revenue Growth	-5.07x
Revenue Growth Q	-6.34x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.69x
Revenue Growth5 Y	-1.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.62
Assets	IDR 14.4T
Cash	IDR 426.6B
Current Assets	IDR 4.3T
Current Liabilities	IDR 6.1T
Debt	IDR 6.8T
Debt EBITDA	IDR 14.87
Debt Equity	IDR 2.38
Debt FCF	IDR 18.88
Equity	IDR 2.9T
Interest Coverage	-0.08
Liabilities	IDR 11.5T
Long Term Assets	IDR 10T
Long Term Liabilities	IDR 5.4T
Net Cash	IDR -6.4T
Net Cash By Market Cap	IDR -180
Net Debt EBITDA	IDR 19.9
Net Debt Equity	IDR 2.23
Net Debt FCF	IDR 17.69
Tangible Book Value	IDR 2.9T
Tangible Book Value Per Share	IDR 513
WACC	7.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.71
Inventory Turnover	3.96
Net Working Capital	IDR 82.2B
Quick ratio	0.27
Working Capital	IDR -1.8T
Working Capital Turnover	IDR -4.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	IDR 0
Last Dividend	IDR 16.33

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-44.4%
1Y total return	36.85%
200-day SMA	530.1
3Y total return	-26.59%
50-day SMA	488.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-75.95%
All Time High	7,575
All Time High Change	-91.62%
All Time High Date	2021-01-12
All Time Low	65
All Time Low Change	876.92%
All Time Low Date	2008-12-04
ATR	29.61
Beta	1.1
Beta1y	0.55
Beta2y	0.68
Ch YTD	23.3
High	635
High52	765
High52 Date	2025-06-13
High52ch	-16.99%
Low	530
Low52	444
Low52 Date	2025-05-08
Low52ch	43.02%
Ma50ch	29.87%
Price vs 200-day SMA	19.78%
RSI	80.11
RSI Monthly	49.15
RSI Weekly	64.8
Sharpe ratio	1.17x
Sortino ratio	2.47
Tr YTD	23.3
Tr15y	275.3%
Tr1m	40.49%
Tr1w	30.12%
Tr3m	24.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	IDR -43B
Operating margin	-0.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	566,588,408%
Net Borrowing	-251,966,587,000
Shares Institutions	4.43%
Shares Out	5,566,588,408
Shares Qo Q	-0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	IDR 360.4B
Average Volume	3,937,400x
Bv Per Share	531.8
CAPEX	IDR -90.6B
Ch10y	-45.96
Ch15y	243.2
Ch1m	40.49
Ch1w	30.12
Ch1y	36.85
Ch20y	262.9
Ch3m	24.51
Ch3y	-26.59
Ch5y	-76.22
Ch6m	9.48
Change	24.51%
Change From Open	19.81
Close	510
Days Gap	3.92
Depreciation Amortization	363,318,843,750
Dollar Volume	39,387,843,500
Earnings Date	2026-06-02
EBIT	IDR -43B
EBITDA	IDR 320.4B
EPS	IDR -28.44
F Score	5
FCF	IDR 360.4B
FCF EV Yield	3.67x
FCF Per Share	IDR 64.74
Financing CF	-179,786,881,000
Fiscal Year End	December
Founded	1,817
Goodwill	53,677,824,000
Income Tax	IDR 10.3B
Investing CF	-97,311,038,000
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2026-03-31
Ma150	531.9
Ma150ch	19.38%
Ma20	501.1
Ma20ch	26.72%
Net CF	175,390,854,000
Next Earnings Date	2026-06-02
Open	530
P FCF Ratio	9.81
P OCF Ratio	7.84
Position In Range	100
Ppne	8,590,473,140,000
Price Date	2026-05-08
Price EBITDA	IDR 11.03
Ptbv Ratio	1.24
Relative Volume	73.57x
Revenue	9,085,769,725,000x
Tax By Revenue	0.11x
Tr20y	325.07%
Tr6m	9.48%
Volume	62,028,100

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IDX/KAEF pay a dividend?

Capital-return profile for this ticker.

Performance

IDX/KAEF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IDX/KAEF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.4%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

0.0%

Negative means the company is buying back shares.

Technical

IDX/KAEF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

80.1

Above 70: short-term overbought

Price vs 200-day MA

+19.8%

50/200-day relationship not available

Beta (5Y)

1.10

Moves roughly with the market

Sharpe ratio

1.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IDX/KAEF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current idx/KAEF stock rating?

idx/KAEF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full idx/KAEF analysis?

The full report lives at /stocks/idx/KAEF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for idx/KAEF?

The latest report frames idx/KAEF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the idx/KAEF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.